GPR35 and Parkinson disease: Furthermore, neuroprotection mediated by pamoic acid, a potent GPR35 agonist, in stroke associates with an increase in Akt phosphorylation [55]; therefore, ZAP may exert its neuroprotective effect in PD model cells based on DJ-1 deficiency either by inhibiting PDEs or by activating GPR35.